Alta Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Hold |
757
| – | – | 0.09% | 199 |
|
|
2025
Q1 | $204K | Buy |
+757
| New | +$204K | 0.09% | 224 |
|
|
2024
Q4 | – | Sell |
-400
| Closed | -$110K | – | 164 |
|
|
2024
Q3 | $110K | Hold |
400
| – | – | 0.05% | 273 |
|
|
2024
Q2 | $97.2K | Hold |
400
| – | – | 0.05% | 269 |
|
|
2024
Q1 | $59.8K | Hold |
400
| – | – | 0.03% | 369 |
|
|
2023
Q4 | $76.6K | Hold |
400
| – | – | 0.04% | 315 |
|
|
2023
Q3 | $70.8K | Hold |
400
| – | – | 0.04% | 310 |
|
|
2023
Q2 | $76K | Hold |
400
| – | – | 0.04% | 311 |
|
|
2023
Q1 | $80.1K | Hold |
400
| – | – | 0.05% | 293 |
|
|
2022
Q4 | $95K | Hold |
400
| – | – | 0.06% | 237 |
|
|
2022
Q3 | $80K | Buy |
+400
| New | +$80K | 0.05% | 258 |
|